SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis - Communications Biology

United Kingdom News News

SARS-CoV-2 Nsp6 damages Drosophila heart and mouse cardiomyocytes through MGA/MAX complex-mediated increased glycolysis - Communications Biology
United Kingdom Latest News,United Kingdom Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 47 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 22%
  • Publisher: 51%

How a SARS-CoV-2 virus protein damages the heart ummedschool nature CommsBio

expression. Adult male flies were maintained in vials in groups of 20 or fewer. The number of living flies in each group was recorded every second day. The assay was carried out until no survivors were left for any of the fly lines. Per genotype 100 flies were assayed.Adult flies were dissected and fixed for 10 min in 4% paraformaldehyde in phosphate-buffered saline . Flies were incubated in block solution containing 0.

was used to process the images. The diastolic dimension and systolic diameter were processed, measured, and determined based on three consecutive heartbeats. The heart rate was determined by counting the total number of beats that occurred during a 15-second recording.For each sample, hearts from fifty-one—week-old adult flies were manually dissected and collected directly into ice-cold TRIzol LS reagent .

Illumina-based RNAseq library preparation and subsequent paired-end sequencing were performed by Novogene . Novogene also carried out mapping of the short-reads, their quantification, and initial differential analyses. In brief, reads that contained Illumina-adaptor sequences or those considered to be of poor quality were removed before mapping. The short-reads, generated from the RNAseq, were mapped to the Berkeley Drosophila Genome Project reference genome release 6 using HISAT2 version 2.0.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Study finds no evidence of major SARS-CoV-2 spread among wild rodentsStudy finds no evidence of major SARS-CoV-2 spread among wild rodentsA new study published in the Emerging Infectious Diseases journal conducted a large-scale serologic survey of SARS-CoV-2 in multiple rodent species to determine the reverse transmission of SARS-Cov-2 and its establishment in wild rodents across different settings.
Read more »

Study shows likely SARS-CoV-2 transmission between different rooms of a quarantine hotelStudy shows likely SARS-CoV-2 transmission between different rooms of a quarantine hotelThe results of this study, published in the Emerging Infectious Diseases journal, underline the enhanced transmissibility of the Omicron variants of the virus, which takes advantage of small airstreams to jump to new hosts. 'Our findings emphasize the importance of ventilation and integrity of building structure in quarantine facilities.'
Read more »

SARS-CoV-2 activates NLRP3 inflammasomeSARS-CoV-2 activates NLRP3 inflammasomeResearchers assessed the role of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the NLR family pyrin domain containing 3 (NLRP3) inflammasome activation.
Read more »

Does the time of day patients receive their COVID-19 vaccinations influence their clinical benefit?Does the time of day patients receive their COVID-19 vaccinations influence their clinical benefit?Does the time of day patients receive their COVID-19 vaccinations influence their clinical benefit? medrxivpreprint WUSTLmed YaleMed COVID19 coronavirus covid vaccinations vaccine vaccination SARSCoV2
Read more »

Study shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbiditiesStudy shows consistent efficacy of Paxlovid regardless of age, number of vaccinations, comorbiditiesIn a recent study posted to the medRxiv* preprint server, researchers in Canada evaluated nirmatrelvir and ritonavir (Paxlovid) effectiveness against severe coronavirus disease 2019 (COVID-19) during the dominance of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern (VOC) and Omicron sub-VOCs in Canada.
Read more »

Paxlovid antiviral therapy reduces risk of long COVIDPaxlovid antiviral therapy reduces risk of long COVIDIn a recent study posted to the medRxiv* server, researchers in Saint Louis, Missouri, examined whether nirmatrelvir treatment reduced the risk of long COVID, the disease encompassing the post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) [PASC].
Read more »



Render Time: 2025-02-24 06:22:49